Paris-headquartered IPF Partners, co-founded by Edouard Guillet in 2011, is targeting a first close for its maiden fund in the second quarter. The fund, IPF I (“Intellectual Property Finance 1”), is targeting €150 million and has a hard cap of €200 million, Guillet confirmed.
IPF 1 will invest in the debt of European pharmaceutical and healthcare companies, leveraging its team’s expertise in the industry.
